Open the map

AbbVieABBV

Big pharma · NYSE · USA

$272.42
Up 0.4% todayClose

Up 18.8% this year and +7.5% since June 26, behind the life science sector at +10.7%. AbbVie supplies 3 mapped companies and buys from 3.

Market cap
$480B
This year
+18.8%
1 year
+16.5%
P/E
76.0
P/S
7.4
P/B
337.7

Price vs the life science sector

since Jun 26ABBVLife science sector, equal weight
AbbVie (ABBV) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. ABBV: +7.5% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−5%0%+5%+10%Jun 26AugSepOct 8ABBV +7.5%Sector +10.7% AbbVie (ABBV) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. ABBV: +7.5% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−5%0%+5%+10%Jun 26AugSepOct 8ABBV+7.5%Sector+10.7%

Supply chain

3 suppliers · 3 customers
SUPPLIERS →→ CUSTOMERSAgilent Technologies (A)AAgilent Technologies−0.5%Waters Corporation (WAT)WATWaters Corporation−1.6%West Pharmaceutical Services (WST)WSTWest Pharmaceutical…−0.9%McKesson (MCK)MCKMcKesson+2.2%Cencora (COR)CORCencora+1.3%Cardinal Health (CAH)CAHCardinal Health+2.9%ABBVAbbVie

Suppliers 3

Customers 3

Open the full chain →

About AbbVie

Skyrizi and Rinvoq carry the immunology franchise. Oncology and neuroscience follow, plus the aesthetics business built around Botox.

Theme exposure

Big biopharmaImmunologyOncologyNeuroscience

Products

  • Skyrizi & Rinvoq (immunology)
  • Oncology portfolio
  • Botox & aesthetics (Allergan)

Competitors

Risks

  • Humira patent loss
  • Pipeline dependence

Same segment: Big pharma

Large, diversified pharmaceutical groups with broad portfolios across therapeutic areas. Segment 2 of 8 in the Medicine, pharma & life science value chain.

Johnson & JohnsonJNJ−0.8%Merck & Co.MRK−0.3%PfizerPFE−0.6%Bristol Myers SquibbBMY−0.2%ZoetisZTS+2.1%

Compare ABBV

Side by side with the largest companies in the same segment.

ABBV vs JNJABBV vs MRKABBV vs PFEABBV vs BMYABBV vs ZTS

See where AbbVie sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →